HCI Group CEO Exercises 20,000 Stock Options
HCI Group, Inc. director and CEO Paresh Patel exercised stock options to acquire additional common shares.
Rhea-AI Filing Summary
HCI Group, Inc. director and CEO Paresh Patel exercised stock options to acquire additional common shares. On February 23, 2026, he exercised options for 20,000 shares of common stock at an exercise price of $40.00 per share, described as an exercise or conversion of a derivative security.
The options were granted under HCI Group’s 2012 Omnibus Incentive Plan, with footnotes noting grant dates, exercise prices and vesting terms. The filing also describes other direct and indirect holdings, including jointly held shares with his spouse and shares held in an IRA.
Positive
- None.
Negative
- None.
Insider Trade Summary
20,000 shares exercised/converted
Exercise
10 txns
Insider
Patel Paresh
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 20,000 | $40.00 | $800K |
| Exercise | Common Stock | 20,000 | $40.00 | $800K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 570,000 contracts for 480,000 underlying shares (Direct);
Common Stock — 1,026,500 shares (Direct);
Common Stock — 37,500 shares (Indirect, IRA)
Footnotes (9)
- F1. Shares held jointly with spouse.
- F2. Restricted stock grant of 10,000 shares effective 2/26/2021: Restricted shares will vest, if ever, on the first anniversary of the date on which the company stock value first equals or exceeds $140 for 30 consecutive days on the applicable exchange. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 2/26/2021.
- F3. The options were granted pursuant to the HCI Group, Inc. 2012 Omnibus Incentive Plan.
- F4. The options were granted on January 7, 2017 at an exercise price of $40.00 per share, in excess of the $39.71 market value. All options have vested and may be exercised at any time up to and including January 7, 2027.
- F5. The options were granted on February 8, 2018 at an exercise price of $40.00 per share, in excess of the $34.92 market value. All options have vested and may be exercised at any time up to and including February 8, 2028.
- F6. The options were granted on January 15, 2019 at an exercise price of $53.00 per share, in excess of the $47.94 market value. All options have vested and may be exercised at any time up to and including January 15, 2029.
- F7. The options were granted on January 16, 2020 at an exercise price of $48.00 per share, in excess of the $45.97 market value. All options have vested and may be exercised at any time up to and including January 16, 2030.
- F8. The options were granted on September 15, 2023 and vested on December 14, 2023 at an exercise price of $70.00 per share when the company stock value first equaled and exceeded $80.00 for 20 consecutive days on the applicable exchange. The options will expire on September 15, 2033.
- F9. Restricted stock grant of 200,000 shares effective 4/17/2024: If at any time the Fair Market Value equals or exceeds $200 for 30 consecutive trading days (the "Vesting Trigger Date"), the restricted shares will vest and the restrictions will lapse as follows. 50,000 of the restricted shares on the later of the Vesting Trigger Date or March 15, 2025; March 15, 2026; March 15, 2027; and March 15, 2028. No portion of the restriction period will lapse six years and one day after the grant date. All remaining restricted shares will be forfeited at that time. These shares were granted by the company pursuant to the company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 4/17/2024.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did HCI (HCI) report for CEO Paresh Patel?
HCI reported that CEO Paresh Patel exercised stock options for 20,000 common shares. The exercise occurred on February 23, 2026 at an exercise price of $40.00 per share, converting previously granted options into directly held HCI Group common stock.
Under what plan were Paresh Patel’s HCI (HCI) options granted?
The options exercised by Paresh Patel were granted under the HCI Group, Inc. 2012 Omnibus Incentive Plan. Footnotes explain multiple grants, including dates, exercise prices, vesting conditions, and expiration dates for these awards, which ultimately allowed him to acquire additional common shares.
What details are given about the pricing of Paresh Patel’s HCI stock options?
The filing notes options with exercise prices such as $40.00, $48.00, $53.00, and $70.00 per share. Several grants were issued at exercise prices above the market value on their grant dates, with all such options now vested and exercisable until their stated expiration dates.
Does the HCI (HCI) Form 4 mention any performance-based or restricted HCI stock for Paresh Patel?
Yes. Footnotes describe restricted stock grants, including 10,000 shares tied to the stock reaching $140 for 30 days and 200,000 shares tied to a $200 price trigger with staged vesting dates through March 15, 2028, subject to specific market-based conditions.
How are Paresh Patel’s indirect HCI (HCI) holdings described in the Form 4?
The filing notes some HCI common stock is held indirectly, including shares in an IRA and shares held jointly with his spouse. These distinctions clarify which positions are direct versus indirect, helping investors understand the structure of his overall HCI Group equity exposure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
